-
Add It UpImmunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.
by Kendall K. Morgan
-
Colorectal Cancer in Young PeopleWhile colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age 50. Younger people are more likely to be diagnosed at a later stage and have unique challenges that come with facing cancer in their prime.
by Erin O’Donnell
-
Men and CancerResearchers are striving to understand why men are more likely than women to get and die from many types of cancer.
by Charlotte Huff
-
Forward Look
Radiation for Advanced Liver CancerStudy results show stereotactic body radiation therapy could be added to standard care.
by Carolyn Bernhardt
-
Forward Look
Blood Test Could Predict Cancer Recurrence and Treatment Side EffectsProtein signatures in the blood could help guide physicians in choosing among different immunotherapy drugs.
by Anna Napolitano
-
Forward Look
Chemotherapy-free Treatment for Advanced Esophageal CancerPhysicians consider which patients are ideal for immunotherapy drug combinations.
by Leah Lawrence
-
From the Editor-in-Chief
One-stop ShoppingTheranostics offers the promise of combining diagnosis and treatment.
by William G. Nelson, MD, PhD
-
The Future of Cancer CareForum discusses next-generation technologies that will guide oncology research and patient care in the years to come.
by Thomas Celona
-
Cervical Cancer Found at Later Stages After 65A study found women in California were more likely to have cervical cancer diagnoses at a later stage after age 65.
by Jon Kelvey
-
Consider Immunotherapy Before Surgery for MelanomaImmunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
